Opthea (ASX: OPT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Opthea Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Opthea (ASX: OPT)
Latest News
ASX Share Market News
The Opthea (ASX:OPT) share price up after receiving FDA approval
Share Gainers
Why Codan, Evolution, Opthea, & People Infrastructure shares are charging higher
ASX Share Market News
Why the Opthea (ASX:OPT) share price is soaring 11% today
Share Fallers
Why Cleanaway, Crown, Opthea, & Zoono shares are sinking lower today
Growth Shares
2 exciting ASX mid cap ASX growth shares to buy for the long term
⏸️ ASX Shares
2 exciting ASX healthcare shares to buy for the long term
ASX Share Market News
Opthea share price bounces with Nasdaq listing on the cards
Share Gainers
Opthea share price surges higher on FDA news
⏸️ Investing
Why Opthea shares could offer big growth potential
ASX Share Market News
Why the Opthea share price surged more than 20% today
ASX Share Market News
Why these 9 ASX shares have doubled in value in the past year
ASX Share Market News
Brokers name 3 ASX shares to buy right now
Frequently Asked Questions
-
No, Opthea does not pay shareholder dividends at this time.
-
Opthea Limited listed on the ASX on 18 April 1991.
OPT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Opthea
Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company. Following the failure of its Phase 3 wet age-related macular degeneration (AMD) trials, the company discontinued that program and relaunched in June 2026 with a new focus on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung disease.
Shareholders have been asked to approve a proposed name change to Ceryvyn Therapeutics to reflect the new direction.
OPT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 08 Jul 2026 | $0.01 | $0.00 | 0.00% | 7,777,329 | $0.01 | $0.02 | $0.01 |
| 07 Jul 2026 | $0.01 | $0.00 | 0.00% | 4,723,387 | $0.02 | $0.02 | $0.01 |
| 06 Jul 2026 | $0.02 | $0.00 | 0.00% | 9,873,809 | $0.02 | $0.02 | $0.01 |
| 03 Jul 2026 | $0.01 | $0.00 | 0.00% | 3,708,050 | $0.02 | $0.02 | $0.01 |
| 02 Jul 2026 | $0.02 | $0.00 | 0.00% | 19,796,064 | $0.02 | $0.02 | $0.01 |
| 01 Jul 2026 | $0.01 | $0.00 | 0.00% | 27,096,878 | $0.02 | $0.02 | $0.01 |